Area of research
Pharmaceutical Science · Biomaterials
Research interest
Research interests include Nanoparticle-Based Drug Delivery, Advanced Drug Delivery Systems, Nanoplatforms for cancer theranostics, and Drug Solubulity and Delivery Systems.
Butylphthalide nanoemulsion for management of dry age-related macular degeneration via antioxidant and anti-inflammatory mechanisms
MMP-9 responsive hyaluronic acid hydrogel for stage-specific treatment of rheumatoid arthritis
Harnessing semen-derived exosomes for noninvasive fundus drug delivery: A paradigm for exosome-based ocular fundus therapeutics
Sustained-Release Nintedanib-Loaded Microspheres for the Treatment of Idiopathic Pulmonary Fibrosis
Decoupling efficacy from toxicity: Inhalable liposomal nintedanib for safe and effective treatment of pulmonary fibrosis
A Macrophage-Driven Multimodal Nanoplatform Conquers Ovarian Cancer Peritoneal Metastasis
A bedside-savior for insomnia and anxiety disorders: melatonin/buspirone hydrochloride compound oral fast-dissolving film
Dual-targeted and ROS-responsive dexamethasone prodrug liposomes for enhanced therapy of acute lung injury
Sustained intraocular delivery of nintedanib via PLGA implant eradicates pathological angiogenesis in retinal neovascularization
A sea buckthorn seed oil nano-emulsion in the management of digital screen-induced ocular conditions
Phospholipid-stabilized atropine nanoemulsion for pediatric myopia control: enhanced ocular retention, permeability, stability
Nanocrystallization and Microencapsulation of Natural Pigments for Improved Dissolution and Stability
A triamcinolone acetonide palmitate nanoemulsion eye drop delivered by iontophoresis for the management of posterior uveitis
Drug–Excipient Interaction-Mediated Supersaturated Emulsion Gel for Enhanced Intradermal Delivery of Tranexamic Acid
Optimizing Particle Size of pH Modifiers Enhances Dissolution of Weakly Basic Drugs
Oxygen-Generating Transdermal Nanoplatform Codelivering BRD4 Proteolysis-Targeting Chimera/Verteporfin/CaO<sub>2</sub> Synergistically Remodels Immunosuppressive Melanoma Microenvironment to Potentiate Combination Immunotherapy
Harnessing macrophages for precision drug delivery and cancer therapy: Strategies, advances and challenges
Dual-phase release finasteride-loaded microspheres for androgenetic alopecia treatment: rapid intervention and sustained control of dihydrotestosterone
Harnessing the apical sodium-dependent bile acid transporter for enhanced oral delivery of peptide drugs: mechanisms, strategies, and therapeutic potential
Dual-phase exenatide delivery system: PLGA nanoparticles embedded in thermosensitive PLGA-PEG-PLGA hydrogel for sustained glycemic control
Oral Dosed Organo‐Silica Nanoparticles Restore Glucose Homeostasis and β‐Cell Function in Diabetes Rats
Design, Synthesis, and Biological Evaluation of a Series of Novel LFA-1 Antagonists with Enhanced Potency and Ocular Safety for Dry Eye Disease
Milk Exosome–Liposome Hybrid Vesicles with Self-Adapting Surface Properties Overcome the Sequential Absorption Barriers for Oral Delivery of Peptides
Advancing nanotechnology for neoantigen-based cancer theranostics
Tumor cells are under siege from all sides: Tumor Cell-Mimic Metal−Organic framework nanoparticles triggering Cuproptosis/Ferroptosis/Apoptosis for Chemo-Chemodynamic-Photothermal-Immunological synergistic antitumor therapy
Phacogoniotomy versus phacotrabeculectomy for advanced primary angle-closure glaucoma with cataract: A randomized non-inferiority trial
Enhancement of gemcitabine sensitivity in intrahepatic cholangiocarcinoma through Saikosaponin-a mediated modulation of the p-AKT/BCL-6/ABCA1 axis
Dual-Targeted Self-Adjuvant Heterocyclic Lipidoid@Polyester Hybrid Nanovaccines for Boosting Cancer Immunotherapy
Novel solid self-emulsifying drug delivery system to enhance oral bioavailability of cabazitaxel
Intramuscular injection of palmitic acid-conjugated Exendin-4 loaded multivesicular liposomes for long-acting and improving
<i>in-situ</i>
stability